Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | ABL1 | P00519 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | PKM | P14618 | 1/20 | 0.67 |
| ▸ | IDE | P14735 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | HLCS | P50747 | 4/20 | 0.48 |
| ▸ | CA12 | O43570 | 10/20 | 0.47 |
| ▸ | CA1 | P00915 | 10/20 | 0.47 |
| ▸ | CA2 | P00918 | 10/20 | 0.47 |
| ▸ | CA9 | Q16790 | 10/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biotin SCHEMBL1270216 | 1.00 | TDP1 (0.67) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL2192463 | 0.95 | TDP1 (0.60) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL1215022 | 0.84 | TDP1 (0.90) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL28780778 | 0.84 | TDP1 (0.90) | TDP1MEN1ABL1LMNAPKM | |
| SCHEMBL29613855 | 0.84 | TDP1 (0.57) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL4433162 | 0.83 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL1523072 | 0.83 | TDP1 (0.71) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL28622397 | 0.82 | TDP1 (0.67) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL486785 | 0.82 | TDP1 (0.81) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL437052 | 0.82 | TDP1 (0.81) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023149585-A1 | CELL LABELLING METHOD | 国立研究開発法人理化学研究所 | 2023-08-10 | — | — | WO | claimed |
| EP-1883394-B1 | LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL | SDG INC (US) | 2018-03-28 | — | — | EP | claimed |
| CN-117964767-A | Anti-RAGE antibodies, extracellular vesicles, methods of making and uses thereof | 北京恩泽康泰生物科技有限公司 | 2024-05-03 | — | — | CN | disclosed |
| WO-2023149585-A1 | CELL LABELLING METHOD | 国立研究開発法人理化学研究所 | 2023-08-10 | — | — | WO | disclosed |
| WO-2023143610-A2 | C-TERMINAL FRAGMENT OF APOLIPOPROTEIN E AND APPLICATION THEREOF IN INHIBITING γ-SECRETASE ACTIVITY | 斯莱普泰(上海)生物医药科技有限公司 | 2023-08-03 | — | — | WO | disclosed |
| EP-3625335-A1 | IMMOBILIZED ENZYME COMPLEXES AND RELATED METHODS | The Curators of the University of Missouri (US) | 2020-03-25 | — | — | EP | disclosed |
| WO-2018213482-A1 | IMMOBILIZED ENZYME COMPLEXES AND RELATED METHODS | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2018-11-22 | — | — | WO | disclosed |
| US-9572833-B2 | Treatment of red blood cells | THE GENERAL HOSPITAL CORPORATION (US) | 2017-02-21 | — | — | US | disclosed |
| US-20140286921-A1 | TREATMENT OF RED BLOOD CELLS | THE GENERAL HOSPITAL CORPORATION | 2014-09-25 | — | — | US | disclosed |
| EP-2776047-A1 | TREATMENT OF RED BLOOD CELLS | The General Hospital Corporation (US) | 2014-09-17 | — | — | EP | disclosed |
| WO-2013070592-A1 | TREATMENT OF RED BLOOD CELLS | THE GENERAL HOSPITAL CORPORATION (US) | 2013-05-16 | — | — | WO | disclosed |
| US-5703081-A | CELL ADHESION INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-12-30 | — | — | US | disclosed |
| US-5536643-A | Non-radioactive method for determining circulating red cell volume, total blood volume, and red cell survival | BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS (US) | 1996-07-16 | — | — | US | disclosed |
| US-5519024-A | CELL ADHESION INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-05-21 | — | — | US | disclosed |
| EP-0614664-A1 | Quinolonecarboxylic acid derivatives, their preparation and their use as cell adhesion inhibitors | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-14 | — | — | EP | disclosed |
| EP-0484452-A1 | FIBULIN | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1992-05-13 | — | — | EP | disclosed |
| WO-1991002755-A1 | FIBULIN | LA JOLLA CANCER RESEARCH FOUNDATION (US) | 1991-03-07 | — | — | WO | disclosed |
| EP-0195009-B1 | CHEMICALLY MARKED NUCLEIC ACIDS, UTILIZATION THEREOF AND KIT FOR ITS IMPLEMENTATION | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1989-09-06 | — | — | EP | disclosed |
| EP-0195009-A1 | CHEMICALLY MARKED NUCLEIC ACIDS, UTILIZATION THEREOF AND KIT FOR ITS IMPLEMENTATION. | INST NAT SANTE RECH MED (FR) | 1986-09-24 | — | — | EP | disclosed |
| WO-1986000074-A1 | CHEMICALLY MARKED NUCLEIC ACIDS, UTILIZATION THEREOF AND KIT FOR ITS IMPLEMENTATION | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M (FR) | 1986-01-03 | — | — | WO | disclosed |